Cohen Klingenstein LLC Takeda Pharmaceutical CO LTD Transaction History

Cohen Klingenstein LLC

  • $2.65 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022
SELL
$13.17 - $16.4 $26,181 - $32,603
-1,988 Reduced 8.03%
22,771 $310,000
Q3 2021

Oct 15, 2021
SELL
$16.3 - $17.26 $52,991 - $56,112
-3,251 Reduced 11.61%
24,759 $406,000
Q1 2019

Apr 16, 2019
BUY
$16.7 - $21.52 $467,767 - $602,775
28,010 New
28,010 $571,000

Others Institutions Holding TAK

# of Institutions
340
Shares Held
76.2M
Call Options Held
1.85M
Put Options Held
121K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Cohen Klingenstein LLC Portfolio

Follow Cohen Klingenstein LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Klingenstein LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email